Journals / Türkderm-Deri Hastalıkları ve Frengi Arşivi / 2012 / Cilt: 46 - Sayı: 1

Efficacy of topical sodium sulfacetamide in the treatment of mild and moderate acne vulgaris: A randomized, comparative study

Hafif ve orta şiddetli akne vulgaris tedavisinde sodyum sulfasetamidin etkinliği: Randomize, karşılaştırmalı çalışma

Pages
33–38
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Statistically significant decrease was obtained with all 3 treatment regimens at the end of the study (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background and Design: Clindamycin and erythromycin are the most widely used topical antibiotics in the treatment of mild to moderate acne vulgaris.
📊
Key Findings & Data:The combination of topical antibiotics with benzoyl peroxide increases the efficacy of the treatment and reduces antibiotic resistance of Propionibacterium acnes.
💡
Conclusion & Impact:Statistically significant decrease was obtained with all 3 treatment regimens at the end of the study (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Background and Design: Clindamycin and erythromycin are the most widely used topical antibiotics in the treatment of mild to moderate acne vulgaris. The combination of topical antibiotics with benzoyl peroxide increases the efficacy of the treatment and reduces antibiotic resistance of Propionibacterium acnes. Sodium sulfacetamide is a sulfonamide antibiotic. Although it has been known for many years, it is not widely used in acne treatment. However, it has recently acquired currency again. In this study, we aimed to assess the efficacy of sodium sulfacetamide in the treatment of mild to moderate acne vulgaris and to compare with the other widely used topical antibiotics.Material and Method: In our comparative study, 60 patients with acne vulgaris were randomly assigned into 3 groups, wherein the 1st, 2nd, and 3rd groups were applied sodium sulfacetamide 10% lotion, clindamycin 1% lotion, and erythromycin 2% gel, respectively, twice daily for 12 weeks. Each group consisted of 20 subjects. The treatment was combined with benzoyl peroxide in all groups. The patients were assessed for noninflammatory (open and closed comedones) and inflammatory (papules and pustules) lesion counts at 4, 8, and 12 weeks and, adverse events were recorded. Results: There was no significant difference between the groups for age, sex and acne duration (p>0.05). Statistically significant decrease was obtained with all 3 treatment regimens at the end of the study (p

Özet

Amaç: Hafif ve orta dereceli akne vulgariste en çok kullanılan topikal antibiyotikler klindamisin ve eritromisindir. Topikal antibiyotiklerin benzoil peroksit ile kombinasyonu etkinliği artırır ve Propionibacterium acnes’e karşı gelişen antibiyotik direncini azaltır. Sodyum sulfasetamid sülfonamid grubu bir antibiyotiktir. Uzun yıllardır bilindiği halde akne tedavisinde fazlaca yer almamaktadır. Ancak son zamanlarda kullanımı tekrar gündeme gelmiştir. Çalışmamızda hafif ve orta derecedeki akne vulgariste sodyum sulfasetamidin etkinliğini klindamisin ve eritromisin ile karşılaştırmalı olarak değerlendirmeyi amaçladık.Gereç ve Yöntem: Karşılaştırmalı çalışmamızda akne vulgarisli 60 hasta, birinci grup sodyum sulfasetamid %10 losyon, ikinci grup klindamisin %1 losyon ve üçüncü grup eritromisin %2 jel 12 hafta süre ile günde iki kez uygulamak üzere, randomize olarak 3 gruba ayrıldı. Her grupta 20 olgu yer aldı. Tedavi tüm hastalarda benzoil peroksit %5 losyon ile kombine edildi. Hastalar başlangıçta, 4, 8 ve 12. haftalarda noninflamatuvar (açık ve kapalı komedo) ve inflamatuvar (papül ve püstül) lezyon sayıları açısından değerlendirildi ve yan etkiler kaydedildi. Bulgular: Gruplar arasında yaş, cinsiyet ve akne süresi yönünden anlamlı fark yoktu (p>0,05). Çalışma sonunda her 3 tedavi yöntemi ile de istatistiksel olarak anlamlı azalma saptandı (p

🔖

Cite This Article

BAŞKAN, E. B., AYDOĞAN, K., TURAN, H., TURAN, A., SARICAOĞLU, H. (2022). Efficacy of topical sodium sulfacetamide in the treatment of mild and moderate acne vulgaris: A randomized, comparative study. Türkderm-Deri Hastalıkları ve Frengi Arşivi, Cilt: 46 - Sayı: 1, 33–38. https://ajindex.com/articles/621933

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (20)

  1. Acar MA, Aksungur VL: Akne ve benzeri hastalıklar. Dermatoloji. Ed. Tüzün Y, Gurer MA, Serdaroğlu S, Oğuz O, Aksungur VL. 3’üncü baskı. İstanbul, Nobel Tıp Kitabevleri, 2008; 1189-205
  2. Zaenglein AL, Thiboutot DM: Acne vulgaris. Dermatology. Ed. Bolognia JL, Jorizzo JL, Rapini RP. 2’inci baskı. London, Mosby, 2008; 495-509
  3. Cunliffe WJ: Acne. 1’inci baskı. London, Martin Dunitz, 1989;178-251
  4. Gollnick H: Current concepts of the pathogenesis of acne: implications for drug treatment. Drugs 2003;63:1579-96
  5. Jeremy AH, Holland DB, Roberts SG, Thomson KF, Cunliffe WJ: Inflammatory events are involved in acne lesion initiation. J Invest Dermatol 2003l;121:20-7
  6. Guy R, Green MR, Kealey T: Modeling acne in vitro. J Invest Dermatol 1996;106:176-82
  7. Leyden JJ, McGinley KJ, Vowels B: Propionibacterium acnes colonization in acne and nonacne. Dermatology 1998;196:55-8
  8. Jarrousse V, Castex-Rizzi N, Khammari A, Charveron M, Dréno B: Modulation of integrins and filaggrin expression by Propionibacterium acnes extracts on keratinocytes. Arch Dermatol Res 2007;299:441-7
  9. Yan AC: Current concepts in acne management. Adolesc Med Clin 2006;17:613-37
  10. Pochi PE, Shalita AR, Strauss JS, et al: Report of the consensus conference on acne classification. J Am Acad Dermatol 1991;24:495-500
  11. Gollnick HP, Krautheim A: Topical treatment in acne: current status and future aspects. Dermatology 2003;206:29-36
  12. Ross JI, Snelling AM, Carnegie E, et al: Antibiotic-resistant acne: lessons from Europe. Br J Dermatol 2003;148:467-78
  13. Tucker SB, Tausend R, Cochran R, Flannigan SA: Comparison of topical clindamycin phosphate, benzoyl peroxide, and a combination of the two for the treatment of acne vulgaris. Br J Dermatol 1984;110:487-92
  14. Burke B, Eady EA, Cunliffe WJ: Benzoyl peroxide versus topical erythromycin in the treatment of acne vulgaris. Br J Dermatol 1983;108:199-204
  15. Leyden J, Levy S: The development of antibiotic resistance in Propionibacterium acnes. Cutis. 2001;67(2 Suppl):21-4
  16. Gollnick H, Cunliffe W, Berson D, et al: Management of acne: a report from a global alliance to improve outcomes in acne. J Am Acad Dermatol. 2003;49(1 Suppl):S1-37
  17. Baker K: Synergistic acne therapy. Southwest Med 1956;37:287
  18. Neidorff AH: A new concept in the treatment of acne vulgaris. Ohio Med 1957;53:293-4
  19. Olansky S: Re-evaluation of sulfacetamide as a topical agent in the treatment of pustular acne. Cutis 1967;3:611-4
  20. Tarimci N,